carbon tetrachloride has been researched along with lysophosphatidic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, J; Arai, H; Arai, M; Fujiwara, K; Ikeda, H; Kume, Y; Nakamura, K; Nishikawa, T; Ohkawa, R; Omata, M; Tejima, K; Tomiya, T; Watanabe, N; Yanase, M; Yatomi, Y | 1 |
| Baader, M; Bretschneider, T; Broermann, A; Kuttruff, CA; Mark, M; Rippmann, JF; Stierstorfer, B | 1 |
2 other study(ies) available for carbon tetrachloride and lysophosphatidic acid
| Article | Year |
|---|---|
Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.
Topics: Animals; Carbon Tetrachloride; Hepatectomy; Liver; Lysophospholipids; Male; Phosphoric Diester Hydrolases; Pyrophosphatases; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2007 |
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis.
Topics: Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Carbon Tetrachloride; Drug Evaluation, Preclinical; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Lysophospholipids; Male; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley | 2018 |